Homology-based Morphometry of Brain Atrophy: Methods and Applications
Donato Quiccione, Mariam Pirashvili, Nathan Broomhead, Sean J. Fallon
TLDR
This paper introduces two persistent homology-based pipelines for brain atrophy analysis, offering interpretable topological biomarkers without nonlinear registration.
Key contributions
- Introduces two persistent homology pipelines for quantifying multiscale brain atrophy from T1-weighted MRI.
- Pipeline 1 quantifies regional thinning for cross-sectional analysis, separating AD from CN with high accuracy (AUC=0.895).
- Pipeline 2 measures structural similarity for longitudinal tracking, detecting disease-related changes in AD patients.
- Avoids problematic nonlinear registration, preserving subject-specific geometric features in brain atrophy analysis.
Why it matters
Current brain atrophy methods struggle with subject-specific features and pathology due to normalization. This paper offers a novel, robust approach using topological data analysis. Its pipelines provide interpretable biomarkers for both cross-sectional and longitudinal studies, improving disease detection and tracking.
Original Abstract
Understanding the structure of the brain, and how it changes with time and disease, is a core goal of structural neuroimaging. Contemporary approaches to structural brain analysis are dominated by voxel-wise, mass-univariate methods such as voxel-based morphometry (VBM). However, these techniques require images to be normalized to a standard template, which can obscure subject-specific geometric features. Normalization to a common stereotactic space can also be problematic when comparing groups with substantial brain pathology, lesions, or other anatomical abnormalities. Here, we introduce two complementary pipelines based on persistent homology (PH), a tool from topological data analysis, to quantify multiscale geometric features of structural T1-weighted MRI scans. Pipeline 1 quantifies regional thinning by applying the Euclidean distance transform to tissue masks in a slice-wise manner. Pipeline 2 uses \(α\)-filtrations to measure structural similarity between pairs of scans, capturing sulcal widening and ventricular enlargement. Synthetic experiments with controlled induced lesions showed that Pipeline 1 is best suited to between-subject analyses, whereas Pipeline 2 is better suited to within-subject designs. Applied to real-world data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), Pipeline 1 separated Alzheimer's disease (AD) from cognitively normal (CN) participants using single-modality T1-weighted MRI without nonlinear registration (ROC-AUC = 0.895), with peak effects localized to medial temporal regions. Pipeline 2 captured disease-related longitudinal change, with follow-up scans remaining closest to their own baselines and AD subjects showing greater short-interval change than CN subjects. Together, these pipelines provide interpretable topological biomarkers for cross-sectional group comparisons and longitudinal tracking.
📬 Weekly AI Paper Digest
Get the top 10 AI/ML arXiv papers from the week — summarized, scored, and delivered to your inbox every Monday.